
Kelvin Capital
Description
Kelvin Capital is a prominent Glasgow-based investment syndicate specializing in venture capital for high-growth, globally ambitious companies, primarily within Scotland. Established in 2009, the firm operates as a network of experienced investors who pool capital to back promising early-stage and growth-stage businesses. Their core mission is to identify companies with significant return potential for their investors, often focusing on those eligible for the UK's Enterprise Investment Scheme (EIS) and Seed Enterprise Investment Scheme (SEIS), which offer tax incentives to investors.
The syndicate targets businesses that demonstrate a clear path to market leadership and a viable exit strategy, typically within a 3-5 year timeframe. While sector-agnostic to some extent, their portfolio reflects investments across various innovative industries. Kelvin Capital typically participates in funding rounds, often co-investing alongside other angel investors, venture capital funds, and institutional partners. This collaborative approach allows them to provide substantial capital while leveraging the expertise of a broader investor base.
Since its inception, Kelvin Capital has made a significant impact on the Scottish entrepreneurial ecosystem, having invested over £70 million (approximately $89 million USD) into more than 30 Scottish businesses. This substantial capital injection underscores their commitment to fostering local innovation and economic growth. Their investment range per round typically spans from £250,000 (approximately $317,500 USD) up to £2 million (approximately $2.54 million USD), indicating their capacity to support companies from their initial growth phases through to more mature expansion rounds. The syndicate's hands-on approach and focus on strategic exits are key components of their value proposition to portfolio companies.
Investor Profile
Kelvin Capital has backed more than 78 startups, with 4 new investments in the last 12 months alone. The firm has led 34 rounds, about 44% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series Unknown, Series A rounds (top funding stages).
- Majority of deals are located in United Kingdom, United States.
- Strong thematic focus on Biotechnology, Health Care, Manufacturing.
- Typical check size: $317.5K – $2.5M.
Stage Focus
- Seed (49%)
- Series Unknown (44%)
- Series A (5%)
- Angel (1%)
- Equity Crowdfunding (1%)
Country Focus
- United Kingdom (96%)
- United States (4%)
Industry Focus
- Biotechnology
- Health Care
- Manufacturing
- Telecommunications
- Medical Device
- Electronics
- Satellite Communication
- Wireless
- Consulting
- Energy
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.